In addition, they showed the role of a blocker of this channel, XEN-D0501, and although IgE levels were not altered, the action of this inhibitor resulted in a reduction in the airway inflammation profile, suggesting that TRPV1 blockade attenuates the allergic asthma phenotype. This evidence concerns the gene IGHE and allergic asthma.